149 related articles for article (PubMed ID: 25279197)
1. Prognostic significance of the co-expression of nucleophosmin and trefoil factor 3 in postoperative gastric cancer patients.
Li Y; Sun Z; Liu K; Qiu W; Yao R; Feng T; Xin C; Yue L
Mol Clin Oncol; 2014 Nov; 2(6):1055-1061. PubMed ID: 25279197
[TBL] [Abstract][Full Text] [Related]
2. Impact of NPM, TFF3 and TACC1 on the prognosis of patients with primary gastric cancer.
Ding A; Zhao W; Shi X; Yao R; Zhou F; Yue L; Liu S; Qiu W
PLoS One; 2013; 8(12):e82136. PubMed ID: 24358147
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of TFF1 and increased expression of TFF3 in gastric cancer: correlation with clinicopathological parameters and prognosis.
Im S; Yoo C; Jung JH; Choi HJ; Yoo J; Kang CS
Int J Med Sci; 2013; 10(2):133-40. PubMed ID: 23329884
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Trefoil Factor 3 Expression in Patients with Gastric Cancer.
Taniguchi Y; Kurokawa Y; Takahashi T; Mikami J; Miyazaki Y; Tanaka K; Makino T; Yamasaki M; Nakajima K; Mori M; Doki Y
World J Surg; 2018 Dec; 42(12):3997-4004. PubMed ID: 30039286
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of nucleophosmin/B23 and human epidermal growth factor receptor 2/neu expressions in gastric cancers.
Zhou F; Qiu W; Sun L; Xiang J; Sun X; Sui A; Ding A; Yue L
APMIS; 2013 Jul; 121(7):582-91. PubMed ID: 23489260
[TBL] [Abstract][Full Text] [Related]
6. The value of trefoil factor 3 expression in predicting the long‑term outcome and early recurrence of colorectal cancer.
Morito K; Nakamura J; Kitajima Y; Kai K; Tanaka T; Kubo H; Miyake S; Noshiro H
Int J Oncol; 2015 Feb; 46(2):563-8. PubMed ID: 25405728
[TBL] [Abstract][Full Text] [Related]
7. Expression of trefoil factor family members correlates with patient prognosis and neoangiogenesis.
Dhar DK; Wang TC; Tabara H; Tonomoto Y; Maruyama R; Tachibana M; Kubota H; Nagasue N
Clin Cancer Res; 2005 Sep; 11(18):6472-8. PubMed ID: 16166422
[TBL] [Abstract][Full Text] [Related]
8. TFF3 and HER2 expression and their correlation with survival in gastric cancer.
Gu J; Zheng L; Zhang L; Chen S; Zhu M; Li X; Wang Y
Tumour Biol; 2015 Apr; 36(4):3001-7. PubMed ID: 25514872
[TBL] [Abstract][Full Text] [Related]
9. Significance of TFF3 protein and Her-2/neu status in patients with gastric adenocarcinoma.
Xu CC; Yue L; Wei HJ; Zhao WW; Sui AH; Wang XM; Qiu WS
Pathol Res Pract; 2013 Aug; 209(8):479-85. PubMed ID: 23822993
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic and clinicopathological value of trefoil factor 3 in patients with gastric cancer: a systematic review and meta-analysis.
Zhang CX; Wu CT; Xiao L; Tang SH
Biomarkers; 2021 Mar; 26(2):95-102. PubMed ID: 33401971
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of nucleophosmin in colorectal carcinomas.
Yang YF; Zhang XY; Yang M; He ZH; Peng NF; Xie SR; Xie YF
Asian Pac J Cancer Prev; 2014; 15(5):2021-6. PubMed ID: 24716928
[TBL] [Abstract][Full Text] [Related]
12. [The expression and significance of trefoil factor 3 and SDF-1/CXCR4 biological axis in papillary thyroid carcinoma].
Xue G; Huang J; Zhang H; Zhang W; Wu J; Shang X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan; 28(2):108-12. PubMed ID: 24738314
[TBL] [Abstract][Full Text] [Related]
13. Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis.
Yusup A; Huji B; Fang C; Wang F; Dadihan T; Wang HJ; Upur H
World J Gastroenterol; 2017 Jan; 23(1):110-120. PubMed ID: 28104986
[TBL] [Abstract][Full Text] [Related]
14. TFF3 and survivin expressions associate with a lower survival rate in gastric cancer.
Meng JR; Tang HZ; Zhou KZ; Shen WH; Guo HY
Clin Exp Med; 2013 Nov; 13(4):297-303. PubMed ID: 22996285
[TBL] [Abstract][Full Text] [Related]
15. Combined loss of TFF3 and PTEN is associated with lethal outcome and overall survival in men with prostate cancer.
Abou-Ouf H; Ghosh S; Box A; Palanisamy N; Bismar TA
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1751-1759. PubMed ID: 31129769
[TBL] [Abstract][Full Text] [Related]
16. Trefoil factor family 3 (TFF3) expression and its interaction with estrogen receptor (ER) in endometrial adenocarcinoma.
Mhawech-Fauceglia P; Wang D; Samrao D; Liu S; DuPont NC; Pejovic T
Gynecol Oncol; 2013 Jul; 130(1):174-80. PubMed ID: 23578537
[TBL] [Abstract][Full Text] [Related]
17. Trefoil factor 3 expression in epithelial ovarian cancer exerts a minor effect on clinicopathological parameters.
Hoellen F; Kostara A; Karn T; Holtrich U; El-Balat A; Otto M; Rody A; Hanker LC
Mol Clin Oncol; 2016 Oct; 5(4):422-428. PubMed ID: 27699037
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
Song S; Liu H; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
[TBL] [Abstract][Full Text] [Related]
19. Expression of trefoil factor 3 is decreased in colorectal cancer.
Espinoza I; Agarwal S; Reddy A; Shenoy V; Subramony C; Sakiyama M; Fair L; Poosarla T; Zhou X; Shannon Orr W; Lahr C; Bae S; Al Diffalha S; Manne U; Gomez CR
Oncol Rep; 2021 Jan; 45(1):254-264. PubMed ID: 33210724
[TBL] [Abstract][Full Text] [Related]
20. Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma.
Pandey V; Wu ZS; Zhang M; Li R; Zhang J; Zhu T; Lobie PE
Breast Cancer Res; 2014 Sep; 16(5):429. PubMed ID: 25266665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
